CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape

Chimeric antigen receptor (CAR) T cell therapies have demonstrated remarkable efficacy for the treatment of hematological malignancies. However, in patients with solid tumors, objective responses to CAR-T cell therapy remain sporadic and transient. A major obstacle for CAR-T cells is the intrinsic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez-Garcia, Alba, Palazon, Asis, Noguera-Ortega, Estela, Powell, Daniel J., Guedan, Sonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311654/
https://www.ncbi.nlm.nih.gov/pubmed/32625204
http://dx.doi.org/10.3389/fimmu.2020.01109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311654/
https://www.ncbi.nlm.nih.gov/pubmed/32625204
http://dx.doi.org/10.3389/fimmu.2020.01109

Ejemplares similares